NYSE$PG
Procter & Gamble Co · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Procter & Gamble's Q3 2021 results reflected solid top-line, bottom-line, and cash performance amidst a challenging operating environment.
Procter & Gamble reported a 5% increase in net sales to $18.1 billion for Q3 2021. Organic sales grew by 4%. Diluted net earnings per share increased by 13% to $1.26. The company returned $5 billion to shareholders through dividends and stock repurchases and maintained sales and earnings guidance while raising the outlook for adjusted free cash flow productivity and cash return.
- Net sales increased by 5% compared to the prior year, reaching $18.1 billion.
- Organic sales grew by 4%, driven by increased pricing and positive mix impact.
- Diluted net earnings per share rose by 13% to $1.26.
- The company returned $5 billion to shareholders through dividends and stock repurchases.
Headline financials
Revenue & EPS history
Procter & Gamble · Revenue · Quarterly
$18.1B
Revenue by segment
Procter & Gamble · $18.1B total across 6 segments · Q3 2021
- Fabric & Home Care$6.28B+8.0%34.7%
- Baby, Feminine & Family Care$4.6B-0.0%25.4%
- Beauty$3.32B+9.0%18.3%
- Health Care$2.36B+4.4%13.0%
- Grooming$1.44B+3.6%7.9%
- Corporate$120M—0.7%
Forward guidance
P&G maintained its outlook for fiscal 2021 all-in and organic sales growth in the range of five to six percent versus the prior fiscal year. P&G maintained guidance for core earnings per share growth in the range of eight to ten percent versus fiscal 2020 core EPS of $5.12.
Tailwinds
- Fiscal 2021 all-in sales growth in the range of 5-6%.
- Fiscal 2021 organic sales growth in the range of 5-6%.
- Fiscal 2021 GAAP diluted net earnings per share growth in the range of 8-10%.
- Fiscal 2021 core earnings per share growth in the range of 8-10%.
- Fiscal 2021 adjusted free cash flow productivity to be over 100%.
Headwinds
- Headwinds of approximately $150 million after-tax from foreign exchange impacts.
- More than $200 million after-tax from higher freight costs.
- A headwind from commodity costs of approximately $125 million after-tax.
- Price increases on Baby Care, Feminine Care and Adult Incontinence product categories in the United States to offset a portion of the impact of rising commodity costs.
- The exact amount of the price increase will vary by brand and sub-brand in the range of mid-to-high single digit percentages and will go into effect in mid-September.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
+0.2%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.4%
Avg return
30 days after
60%
43 / 72 earnings
Positive
+7.9%
Q1 2019
Best reaction
-7.2%
Q3 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +1.8% | +0.5% | -0.8% | |
| Q2 2026 | +2.7% | +1.6% | +10.1% | |
| Q1 2026 | -0.5% | -2.3% | -0.8% | |
| Q3 2025 | -3.7% | -2.1% | +0.1% | |
| Q2 2025 | +2.7% | +4.9% | +5.3% | |
| Q1 2025 | -1.6% | -1.6% | -1.6% | |
| Q4 2024 | -5.4% | +0.1% | +0.1% | |
| Q3 2024 | +2.1% | +3.4% | +6.6% | |
| Q2 2024 | +2.9% | +5.6% | +8.6% | |
| Q1 2024 | +1.4% | +1.3% | +3.3% | |
| Q4 2023 | +2.8% | +2.9% | +0.9% | |
| Q3 2023 | +3.6% | +2.5% | +1.5% | |
| Q2 2023 | -2.3% | -3.1% | -4.4% | |
| Q1 2023 | -1.1% | +0.8% | +11.1% | |
| Q4 2022 | -3.5% | -2.1% | -3.9% | |
| Q3 2022 | +2.0% | +2.0% | -11.1% | |
| Q2 2022 | +3.4% | +2.9% | +2.0% | |
| Q1 2022 | -0.8% | -1.1% | +3.4% | |
| Q4 2021 | +1.7% | +2.1% | +2.0% | |
| Q3 2021 | +0.2% | -2.0% | +1.0% | |
| Q2 2021 | -1.9% | -1.0% | -4.9% | |
| Q1 2021 | +0.9% | +0.3% | -1.7% | |
| Q4 2020 | +2.2% | +4.3% | +8.2% | |
| Q3 2020 | -0.7% | -1.7% | -5.7% | |
| Q2 2020 | -0.9% | -0.2% | +0.3% | |
| Q1 2020 | +3.3% | +3.5% | +1.1% | |
| Q4 2019 | +1.8% | +0.4% | +4.5% | |
| Q3 2019 | -2.2% | -0.1% | +0.7% | |
| Q2 2019 | +4.3% | +3.4% | +10.8% | |
| Q1 2019 | +7.9% | +11.5% | +16.9% | |
| Q4 2018 | +0.6% | +2.7% | +4.0% | |
| Q3 2018 | -5.6% | -7.3% | -6.1% | |
| Q2 2018 | -3.9% | -4.5% | -12.0% | |
| Q1 2018 | -4.7% | -5.2% | -3.5% | |
| Q4 2017 | +1.0% | +2.0% | +3.6% | |
| Q3 2017 | -2.6% | -3.2% | -3.1% | |
| Q2 2017 | +2.7% | +2.9% | +7.5% | |
| Q1 2017 | +3.9% | +3.3% | -1.7% | |
| Q4 2016 | -0.5% | -0.7% | +2.2% | |
| Q3 2016 | -1.9% | — | — | |
| Q2 2016 | +2.5% | — | — | |
| Q1 2016 | +3.5% | — | — | |
| Q4 2015 | -4.9% | — | — | |
| Q3 2015 | -2.5% | — | — | |
| Q2 2015 | -4.9% | — | — | |
| Q1 2015 | +3.3% | — | — | |
| Q4 2014 | +2.5% | — | — | |
| Q3 2014 | -0.1% | — | — | |
| Q2 2014 | +0.3% | — | — | |
| Q1 2014 | +0.9% | — | — | |
| Q4 2013 | +1.2% | — | — | |
| Q3 2013 | -7.2% | — | — | |
| Q2 2013 | +4.8% | — | — | |
| Q1 2013 | +2.0% | — | — | |
| Q4 2012 | +3.6% | — | — | |
| Q3 2012 | -4.8% | — | — | |
| Q2 2012 | -2.5% | — | — | |
| Q1 2012 | -0.3% | — | — | |
| Q4 2011 | +0.4% | — | — | |
| Q3 2011 | +1.1% | — | — | |
| Q2 2011 | -1.6% | — | — | |
| Q1 2011 | -0.1% | — | — | |
| Q4 2010 | -0.4% | — | — | |
| Q3 2009 | +0.8% | — | — | |
| Q3 2010 | +0.8% | — | — | |
| Q4 2008 | +0.5% | — | — | |
| Q4 2007 | +0.5% | — | — | |
| Q2 2010 | +1.2% | — | — | |
| Q2 2009 | +1.2% | — | — | |
| Q1 2009 | +1.3% | — | — | |
| Q1 2010 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro